Cargando…
Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association of Urology. Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367783/ https://www.ncbi.nlm.nih.gov/pubmed/34509303 http://dx.doi.org/10.1016/j.eururo.2021.08.003 |
| _version_ | 1783739086077427712 |
|---|---|
| author | Coelingh Bennink, Herjan J.T. Foidart, Jean-Michel Debruyne, Frans M.J. |
| author_facet | Coelingh Bennink, Herjan J.T. Foidart, Jean-Michel Debruyne, Frans M.J. |
| author_sort | Coelingh Bennink, Herjan J.T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8367783 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Association of Urology. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83677832021-08-17 Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 Coelingh Bennink, Herjan J.T. Foidart, Jean-Michel Debruyne, Frans M.J. Eur Urol Letter to the Editor European Association of Urology. Published by Elsevier B.V. 2021-11 2021-08-17 /pmc/articles/PMC8367783/ /pubmed/34509303 http://dx.doi.org/10.1016/j.eururo.2021.08.003 Text en © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Coelingh Bennink, Herjan J.T. Foidart, Jean-Michel Debruyne, Frans M.J. Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title | Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title_full | Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title_fullStr | Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title_full_unstemmed | Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title_short | Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| title_sort | reply to bexultan kazybay and yingqiu xie’s letter to the editor re: herjan j.t. coelingh bennink, jean-michel foidart, frans m.j. debruyne. treatment of serious covid-19 with testosterone suppression and high-dose estrogen therapy. eur urol. in press. https://doi.org/10.1016/j.eururo.2021.06.024 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367783/ https://www.ncbi.nlm.nih.gov/pubmed/34509303 http://dx.doi.org/10.1016/j.eururo.2021.08.003 |
| work_keys_str_mv | AT coelinghbenninkherjanjt replytobexultankazybayandyingqiuxieslettertotheeditorreherjanjtcoelinghbenninkjeanmichelfoidartfransmjdebruynetreatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapyeururolinpresshttpsdoiorg101016jeururo202106024 AT foidartjeanmichel replytobexultankazybayandyingqiuxieslettertotheeditorreherjanjtcoelinghbenninkjeanmichelfoidartfransmjdebruynetreatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapyeururolinpresshttpsdoiorg101016jeururo202106024 AT debruynefransmj replytobexultankazybayandyingqiuxieslettertotheeditorreherjanjtcoelinghbenninkjeanmichelfoidartfransmjdebruynetreatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapyeururolinpresshttpsdoiorg101016jeururo202106024 |